Aeterna Zentaris

Every New FDA Drug Approval in 2017
Every New FDA Drug Approval in 2017The last 12 drugs approved in the year, along with the other 34.
Uro Pipeline: Phase III data show drug’s benefit in castrate-resistant PCaOther pipeline products discussed in this article include agents for urinary catheter blockage, prostate cancer, bladder cancer, and overactive bladder.
Urology Product PreviewUrology drugs and devices in the pipeline from AngioDynamics, Tetraphase Pharmaceuticals, Bellicum Pharmaceuticals, Competitive Technologies, Xion Pharmaceuticals, Jubilant Biosys, NewLink Genetics, Exosome Diagnostics, QIAGEN N.V., Aeterna Zentaris, and CureVac GmbH.